Public Reporting
Review our ACO structure and historical performance
ACO Name and Location
South Texas ACO Clinical Partners LLC
ACO Organizational Information
ACO Participants
| ACO Participants | ACO Participant in Joint Venture (Enter Y or N) |
| Adonis Zuniga-Goldwater MD | N |
| Adult Health Clinic | N |
| Agustin B Mego Md Pa | N |
| ALLIANCE IN HEALTH PLLC | N |
| Andres Garcia Zuniga, M.D.,PA | N |
| Armando R Hinojosa, M.D., PA | N |
| Arturo Garza Gongora | N |
| BEACON HEALTH CARE PA | N |
| Benjamin Fano MD PA | Y |
| Carlos G. Cigarroa, M.D., PA | N |
| Carlos Hornedo | N |
| Carlose Llanes | N |
| CARLOS N HORNEDO III DO PA | N |
| Clinica Sagrado Corazon | N |
| David H Cruz MD PA | N |
| Dennis Cantu | N |
| Dr. Americo M Baca PLLC | N |
| Dr. Sergio Zamora, PA | N |
| Eloy Zamarron, Jr MD, PA | Y |
| FAMILY CARE SPECIALISTS, LLC | N |
| FAMILY HEALTH CENTER OF MISSION PLLC | N |
| Family Medicine Associates PA | N |
| Garza Medical Associates | Y |
| Haitham Jifi, MD PA | N |
| Humberto Varela, MD | N |
| JOSE A ESCANDON, MD PA | N |
| Jose Garcia | Y |
| Jose Roel Maldonado Jr MD PA | N |
| Juana Maria Espejo Md Pa | N |
| Kallumadanda PLLC | N |
| LAREDO MINOR EMERGENCY CLINIC PA | Y |
| Laredo Physicians Group | N |
| Laredo Premier Healthcare, PLLC | Y |
| Luis Benavides | Y |
| Marissa R. Gonzalez, MD PLLC | N |
| MARY PLATTNER | N |
| McAllen Hospitalist Group, PLLC | Y |
| Miguel Villarino MD PA | N |
| MONZER H YAZJI MD & ASSOCIATES PA | Y |
| Pablo Olmedo | N |
| RAFAEL J DELIZ MD PA | N |
| Ruben D Bocanegra MD PA | Y |
| South Laredo Family Clinic PA | Y |
| Texas Lone Star Physician Services, PLLC | N |
| VALLEY MEDICAL ARTS CLINIC PA | N |
| Victoriano Valdez, MD PA | N |
| Winder Vasquez | N |
ACO Governing Body
| Last name | First name | Title/Position | Member’s voting power (expressed as a percentage or number) | Membership type | ACO participant legal business name/DBA, if applicable |
|---|---|---|---|---|---|
| Yazji | Monzer | Chair | 1 | ACO Participant Representative | Monzer H Yazji MD & Associates PA |
| Benavides | Luis | Physician | 1 | ACO Participant Representative | Laredo Premier Healthcare, PLLC |
| Garza-Gongora | Arturo | Physician | 1 | ACO Participant Representative | Arturo Garza Gongora |
| Contreras | Daniel | Physician | 1 | ACO Participant Representative | ASAS - Family Health Center of Mission |
| Solis | Joel | Physician | 1 | ACO Participant Representative | ASAS - Laredo Premier Healthcare |
| Reyes | Mateo | Physician | 1 | ACO Participant Representative | Mateo Reyes |
| Stark | Chuck | Other | 1 | ACO Participant Representative | South Texas Health System Clinics |
| Jemmoua | Kamal | Other | 1 | Administration | N/A |
| Medina | Jorge | Other | 1 | Consumer Advocate | N/A |
| Sherwood | Carol | Other | 1 | Medicare Beneficiary Representative | N/A |
Key ACO clinical and administrative leadership
ACO Executive: Kamal Jemmoua
Medical Director: Monzer Yazji
Compliance Officer: Philip Ramirez
Quality Assurance/Improvement Officer: Dr. Luis Benavides
Associated committees and committee leadership
| Committee Name | Committee Leader Name and Position |
|---|---|
| Clinical Committee | Dr. Joel Solis, Chair |
| Finance Committee | Dr. Garza-Gongora, Chair |
| Quality Assurance and Improvement Committee | Dr. Luis Benavides, Chair |
Types of ACO participants, or combinations of participants, that formed the ACO:
• ACO professionals in a group practice arrangement
• Networks of individual practices of ACO professionals
Shared Savings and Losses
Amount of Shared Savings/Losses
- Second Agreement Period
- Performance Year 2021, $7,021,761
- Performance Year 2020, $7,016,439
- First Agreement Period
- Performance Year 2019, $8,632,047
- Performance Year 2018, $6,752,936
- Performance Year 2017, $0
Shared Savings Distribution
- Second Agreement Period
- Performance Year 2021
- Proportion invested in infrastructure: 10%
- Proportion invested in redesigned care processes/resources: 20%
- Proportion of distribution to ACO participants: 70%
- Performance Year 2020
- Proportion invested in infrastructure: 10%
- Proportion invested in redesigned care processes/resources: 20%
- Proportion of distribution to ACO participants: 70%
- Performance Year 2021
- First Agreement Period
- Performance Year 2019
- Proportion invested in infrastructure: 10%
- Proportion invested in redesigned care processes/resources: 20%
- Proportion of distribution to ACO participants: 70%
- Performance Year 2018
- Proportion invested in infrastructure: 10%
- Proportion invested in redesigned care processes/resources: 20%
- Proportion of distribution to ACO participants: 70%
- Performance Year 2017
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2019
Quality Performance Results
2021 Quality Performance Results:
Quality performance results are based on the CMS Web Interface.
| Meaure # | Measure Name | Rate | ACO Mean |
| ACO-1 | CAHPS: Getting Timely Care, Appointments, and Information | 87.52 | 84.67 |
| ACO-2 | CAHPS: How Well Your Providers Communicate | 93.98 | 93.56 |
| ACO-3 | CAHPS: Patients’ Rating of Provider | 92.62 | 92.19 |
| ACO-4 | CAHPS: Access to Specialists | 85.04 | 78.80 |
| ACO-5 | CAHPS: Health Promotion and Education | 64.27 | 61.61 |
| ACO-6 | CAHPS: Shared Decision Making | 64.41 | 60.89 |
| ACO-7 | CAHPS: Health Status/Functional Status | 68.09 | 71.78 |
| ACO-34 | CAHPS: Stewardship of Patient Resources | 29.17 | 24.71 |
| ACO-45 | CAHPS: Courteous and Helpful Office Staff | 91.87 | 91.88 |
| ACO-46 | CAHPS: Care Coordination | 86.00 | 85.66 |
| ACO-13 | Falls: Screening for Future Fall Risk | 91.03 | 87.03 |
| ACO-14 | Preventive Care and Screening: Influenza Immunization | 84.82 | 80.52 |
| ACO-17 | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | 96.43 | 80.97 |
| ACO-19 | Colorectal Cancer Screening | 90.57 | 73.63 |
| ACO-20 | Breast Cancer Screening | 73.72 | 75.11 |
| ACO-42 | Statin Therapy for Prevention and Treatment of Cardiovascular Disease | 78.87 | 84.24 |
| ACO-40 | Depression Remission at Twelve Months | 42.42 | 15.50 |
| ACO-27 | Diabetes: Hemoglobin A1c (HvA1c) Poor Control | 13.40 | 12.46 |
| ACO-28 | Controlling High Blood Pressure | 70.91 | 74.87 |
| ACO-8 | Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups | 0.1694 | 0.1540 |
| ACO-38 | All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions for ACOs (MCC) | 28.90 | 33.99 |
- For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov
Payment Rule Waivers
Skilled Nursing Facility (SNF) 3-day Rule Waiver:
Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR §425.612.
Types of ACO participants, or combinations of participants, that formed the ACO
Networks of individual practices of ACO professionals
Hospital employing ACO professionals
